89 related articles for article (PubMed ID: 15193973)
21. Carcinoembryonic antigen in metastatic colorectal cancer.
Hamm CM; Cripps C
Clin Invest Med; 1998; 21(4-5):186-91. PubMed ID: 9800067
[TBL] [Abstract][Full Text] [Related]
22. Analysis for prognostic factors of 60-day mortality: evaluation of an irinotecan-based phase III trial performed in the first-line treatment of metastatic colorectal cancer.
Giessen C; Stintzing S; Laubender RP; Ankerst DP; Schulz C; Moosmann N; Modest DP; Schalhorn A; von Weikersthal LF; Heinemann V
Clin Colorectal Cancer; 2011 Dec; 10(4):317-24. PubMed ID: 21729676
[TBL] [Abstract][Full Text] [Related]
23. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review.
Tol J; Punt CJ
Clin Ther; 2010 Mar; 32(3):437-53. PubMed ID: 20399983
[TBL] [Abstract][Full Text] [Related]
25. Systematic reviews in laboratory medicine: principles, processes and practical considerations.
Horvath AR; Pewsner D
Clin Chim Acta; 2004 Apr; 342(1-2):23-39. PubMed ID: 15026264
[TBL] [Abstract][Full Text] [Related]
26. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1998 Feb; 16(2):793-5. PubMed ID: 9469371
[TBL] [Abstract][Full Text] [Related]
27. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer.
Locker GY; Hamilton S; Harris J; Jessup JM; Kemeny N; Macdonald JS; Somerfield MR; Hayes DF; Bast RC;
J Clin Oncol; 2006 Nov; 24(33):5313-27. PubMed ID: 17060676
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic advances in the management of metastatic colorectal cancer.
Freyer G; Ligneau B; Kraft D; Descos L; Trillet-Lenoir V
Expert Rev Anticancer Ther; 2001 Aug; 1(2):236-46. PubMed ID: 12113029
[TBL] [Abstract][Full Text] [Related]
29. Interventions for Age-Related Macular Degeneration: Are Practice Guidelines Based on Systematic Reviews?
Lindsley K; Li T; Ssemanda E; Virgili G; Dickersin K
Ophthalmology; 2016 Apr; 123(4):884-97. PubMed ID: 26804762
[TBL] [Abstract][Full Text] [Related]
30. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.
Bast RC; Ravdin P; Hayes DF; Bates S; Fritsche H; Jessup JM; Kemeny N; Locker GY; Mennel RG; Somerfield MR;
J Clin Oncol; 2001 Mar; 19(6):1865-78. PubMed ID: 11251019
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of cetuximab in therapy of metastatic colorectal cancer: a system evaluation].
Hou SH; Liang XB; Bai WQ; Yang J; Yan D; Zhang X; Wang LC
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1387-90. PubMed ID: 19671328
[TBL] [Abstract][Full Text] [Related]
32. Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.
Faron M; Pignon JP; Malka D; Bourredjem A; Douillard JY; Adenis A; Elias D; Bouché O; Ducreux M
Eur J Cancer; 2015 Jan; 51(2):166-76. PubMed ID: 25465185
[TBL] [Abstract][Full Text] [Related]
33. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
34. TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer.
Spindler KL; Christensen IJ; Nielsen HJ; Jakobsen A; Brünner N
Tumour Biol; 2015 Jun; 36(6):4301-8. PubMed ID: 25608838
[TBL] [Abstract][Full Text] [Related]
35. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
36. Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials.
Jonker DJ; Maroun JA; Kocha W
Br J Cancer; 2000 Jun; 82(11):1789-94. PubMed ID: 10839292
[TBL] [Abstract][Full Text] [Related]
37. Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.
Ilic I; Jankovic S; Ilic M
PLoS One; 2016; 11(8):e0161912. PubMed ID: 27579775
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
